Unblinded: A Clinical Trial Podcast

Jim Reilly, Veeva's VP of Development Cloud Strategy, joins Richard Young to discuss their takeaways from Veeva's recent North American R&D and Quality Summit. They talk about patient centricity, the future of digital trials, and major updates from Veeva announced at the event.

In this discussion, Andy Cooper, CEO of CluePoints and a veteran in clinical data analytics, tackles the misconceptions surrounding AI in clinical trials. He explains the essential differences between supervised and unsupervised machine learning, emphasizing the need for domain-specific models. Andy highlights the potential of AI to predict site issues and streamline operations by reducing manual tasks. He also addresses concerns about data privacy and trust in AI tools, advocating for consistent results over transparency to build confidence in machine learning.

This week, Richard Young speaks to Tim Davis, vice president of strategy for MyVeeva for Patients. In recent years, decentralized clinical trials, patient centricity, and site centricity have become buzzwords for sponsors and CROs. This episode covers how to cut through the hype and focus on ideas that would both impact patient lives and make things easier for sites. As Tim explains, positive change starts with expanding patient choice during clinical trials. Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released. Spotify: https://lnkd.in/e5pJ7saP Youtube: https://bit.ly/3quY9FY Apple Podcasts: https://lnkd.in/efMTxybk

Host: Richard Young, VP, Strategy, Veeva Vault CDMS Guest: Rhona O’Donnell, VP, Data Management Systems and Standards, Novo Nordisk This week, Richard Young is joined by Rhona O’Donnell, VP, Data Management Systems and Standards at Novo Nordisk. They discuss the evolution of the data management role, and how we can prepare for the future through collaboration and more effective training for the next generation. Richard and Rhona share their thoughts on the growing list of responsibilities facing data managers; why risk-based data management can help make trials more sustainable; the largest opportunities for time savings within the data management world; and the big initiatives that Novo Nordisk is working on to improve their data management processes.  Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released. Spotify: https://lnkd.in/e5pJ7saP Youtube: https://bit.ly/3quY9FY Apple Podcasts: https://lnkd.in/efMTxybk

This week, Richard Young speaks to Alan Morgan, CEO Advisor of Excelya. In recent years, sponsors and CROs have invested heavily in “big data” tools for site selection and productivity. But, has that investment paid off? Richard and Alan discuss whether we’ve come any closer to truly patient-centric trials – and what we still have left to do. From partnering with patient advocacy groups to going back to the basics on data management, this episode covers some new industry initiatives that could make a positive difference for patients. Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS Guest: Luis E. Torres, Head of Clinical Programming FSPx, Labcorp This week, Richard Young speaks to Luis E. Torres, head of Clinical Programming FSPx at LabCorp. They discuss how data managers can prepare for the future of clinical trials by adopting new technologies and skills to keep decentralized clinical teams connected. Richard and Luis share their thoughts on designing studies and processes that support end-user needs; the shifting goal posts of data cleanliness and database build expectations; and why data managers are uniquely positioned to solve the “Rubik’s Cube” of challenges involving people, processes, and technology. Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS Guest: Mayank Anand, VP and Global Head of Data Strategy and Management, GSK In this week’s conversation, Richard Young and Mayank Anand, global head of data strategy and management at GSK and Chair of SCDM, discuss how clinical data professionals’ roles are evolving in a world of decentralized data. It’s a great time to be a clinical data professional, they agree, as a once invisible role moves front and center to optimize trial protocols, operations, and results, and speed patient access to better treatments. SCDM offers professionals a global voice and a forum for discussion and debate, and Mayank summarizes the organization’s key goals. Both Richard and Mayank share insights into understanding end user and patient needs; balancing the needs of different stakeholders; and solving a Rubik’s cube of challenges that involve people, processes, and technology. Mayank also shows how new perspectives are driving a more inclusive strategy and collaborative mindset that is already improving patient focus and business results at GSK and within the industry. Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS Guest: Natalie Townsend, VP, Strategy, Veeva RTSM This week, Richard Young speaks to Natalie Townsend, the global lead for Randomization and Trial Supply Management (RTSM) strategy at Veeva. They discuss the evolution of ‘digital’ clinical trials from the early days of phone-based and spreadsheet-centered activities to the role technology is playing today. Will data management clash, combine, or sit comfortably with the world of site supplies and randomization? And how can technology help with challenges faced by both sides? Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released. Spotify: https://lnkd.in/e5pJ7saP Youtube: https://bit.ly/3quY9FY Apple Podcasts: https://lnkd.in/efMTxybk

Host: Richard Young, Vice President, Vault CDMS Strategy, Veeva Guest: Trevor Griffiths, Senior Director, Clinical Data Management, Syneos Health Description: Host Richard Young speaks to Trevor Griffiths, senior director for clinical data management at Syneos Health. Data management is becoming much more complex for CROs, as trials become larger and data sources more diverse. Yet Syneos was still able to eliminate 3,000 hours of manual review in a single trial through machine learning. As the industry moves to a single view of all clinical study data, will we get clean data ready faster? What does this mean for the role of the data manager? *Veeva CDB refers to Veeva’s clinical data platform for complete and concurrent data (available late 2022). Subscribe to State of Digital Clinical Trials, a Veeva podcast, on Apple or Spotify to get new episodes as soon as they are released. Spotify: https://lnkd.in/e5pJ7saP Youtube: https://bit.ly/3quY9FY Apple Podcasts: https://lnkd.in/efMTxybk

Host: Richard Young, Vice President, Vault CDMS Strategy, Veeva Guest: Doug Bain, Chief Technology Officer, KCR Host Richard Young speaks to Doug Bain, chief technology officer at KCR, a contract research organization (CRO). They discuss the role of electronic data capture (EDC) in today’s complex, dynamic clinical trial landscape. With only a fraction of trial data coming from EDC, are its days numbered? And what are some of the tangible opportunities made possible by digital clinical trials that could ease the burden on sites and patients? Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released. Subscribe to State of Digital Clinical Trials, a Veeva podcast, on Apple (https://go.veeva.com/podcast-digital-...),Spotify (https://go.veeva.com/veeva-digital-tr...), and Youtube ( ) to get new episodes as soon as they are released.